iOmx Therapeutics’ iOTarg™ Genetic Screening Platform Featured in Podium Presentation at PEGS Europe 2019
- Thursday, November 21, 2019, 7:16
- Business
- Add a comment
MARTINSRIED, Germany and MUNICH, Nov. 21, 2019 /PRNewswire/ — iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced today that its Vice President, Antibody Development, Stefanie Urlinger, PhD, delivered…
About the Author
adminasapcorp has written 41842 stories on this site.